Role of JAK2 Beyond Myeloproliferative Neoplasms (MPNs): Rationale for Targeting the JAK-STAT Pathway in Other Hematological Malignancies and Solid Tumors
None
Saved in:
| Main Authors: | McDevitt, Theresa M., Lorenzi, Matthew V. |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2011
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/25042 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Jak-STAT Signal Transduction Pathway in Melanoma
by: Nicholas, Courtney, et al.
Published: (2011) -
Exploration of JAK/STAT pathway activation in ulcerative colitis reveals sex-dependent activation of JAK2/STAT3 in the inflammatory response
by: Cristina Calviño-Suárez, et al.
Published: (2025-07-01) -
JAK-STAT inhibitors in noninfectious uveitis – A review
by: Richa Pyare, et al.
Published: (2025-06-01) -
Incidence, Outcomes and Risk Factors for Atrial Fibrillation in Patients With JAK2V617F‐Positive Myeloproliferative Neoplasms
by: Guangshuai Teng, et al.
Published: (2025-07-01) -
Association between JAK2V617F Mutation and Mean Platelet Volume among Myeloproliferative Neoplasm Patients
by: Mushtaq M. Khazeem, et al.
Published: (2025-04-01)


